论文部分内容阅读
目的:观察中药莲花清肝饮配合介入(TACE术)治疗晚期肝癌的临床疗效。方法:50例原发性肝癌患者随机分为TACE术组和TACE术+中药莲花清肝饮组,观察治疗后无病生存期和总生存期。结果:TACE术组1、2年生存期分别为76%、40%,TACE术+中药莲花清肝饮组1、2年生存期分别为72%、64%,两组2年生存率差异有显著性(P<0.01)。结论:中药莲花清肝饮结TACE术对晚期肝癌可有效延长生存期。
OBJECTIVE: To observe the clinical efficacy of traditional Chinese medicine lotus Qinggan Decoction combined with interventional (TACE) treatment for advanced hepatocellular carcinoma. Methods: Fifty liver cancer patients were randomly divided into TACE surgery group and TACE surgery plus Chinese herbal medicine Qinglian Qinggan Yin group. The disease-free survival and overall survival were observed after treatment. Results: The 1-year and 2-year survival periods of TACE group were 76% and 40%, respectively. The 1-year and 2-year survival periods of TACE and Chinese herbal lotus-qinggan decoction groups were 72% and 64% respectively. There was a difference in 2-year survival rate between the two groups. Significant (P < 0.01). Conclusion: Traditional Chinese medicine lotus Qing Gan Yin TACE surgery can effectively extend the survival period of advanced liver cancer.